FDA Town Hall

11:00 AM - 12:15 PM, Tuesday, June 4, 2019 ・ 113ABC, Level 100
The session will be organized as an interactive, moderated roundtable discussion of FDA center priorities followed by a question-and-answer session with the audience. Topics that will be addressed during the roundtable will include the FDA’s perspectives on critical topics such as PDUFA VI implementation; efforts to advance innovation and expedite patient access to novel therapies for serious and life-threatening conditions; novel approaches to integrating new scientific tools into FDA regulatory practices at all levels; and FDA resources and scientific infrastructure.
Director of the Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration
Director of the Center for Drug Evaluation and Research (CDER)
Food And Drug Administration (FDA)